Top 10 Books about Stock Investing to read in 2018. Read more.

EYES - Second Sight Medical Products

Industry: Medical Appliances & Equipment Sector: Healthcare Exchange: NASDAQ

EYES - Second Sight Medical Products

Industry: Medical Appliances & Equipment Sector: Healthcare Exchange: NASDAQ

Tue 06'th Mar 2018

PERIOD 2017-12-07 - 2018-03-06
CHANGE -0.55%
PRICE $1.80






Second Sight Medical Products Stock Analysis

Technical stock analysis for Tue 06'th Mar 2018

Sell candidate since 2018-03-06

Second Sight Medical Products fell by -0.55% in the last day from $1.81 to $1.80 The price has fallen in 5 of the last 10 days, but is still up by 11.8% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -393 389 shares and in total 400 304 shares bought and sold for approximately $720 547.

Shorts 3.45% ( 2018-02-15 )
Cash 66.2 mill
Loans n/a
Beta 3.43
ROA -135.35


Second Sight Medical Products lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.57% during the next 3 months and, with 90% probability hold a price between $1.24 and $1.84 at the end of this period.

Click here for today's Top 5 Trending Companies


Second Sight Medical Products holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $1.63 and $1.79. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Monday March 05, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 60 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Second Sight Medical Products finds support from accumulated volume at $1.75. On the upside the stock meets some resistance from accumulated volume at $1.91, $2.00 and $2.01.

Support: $1.75 Price: $1.80 Resistance: $1.91


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.11 between high and low, or 6.21%. For the last week the stock has had a daily average volatility of 9.70%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


Second Sight Medical Products holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.

Trade EYES CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).